Form 4: AbbVie Director William H.L. Burnside Reports Changes in Beneficial Ownership

Director William H.L. Burnside reports acquisition and disposal of AbbVie common stock and restricted stock units.

Summary

• On May 3, 2024, William H.L. Burnside, a director of AbbVie Inc., reported changes in beneficial ownership of the company's securities.
• Burnside acquired 1,322 shares of common stock and disposed of 25,755 shares.
• The acquisition of 1,322 shares was related to restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program.
• These restricted stock units will be paid in shares of AbbVie common stock upon separation from service, death, or a change in control.
• T.O. Odutayo, acting as Attorney-in-Fact, signed the report on May 7, 2024.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral.

Future Outlook

The restricted stock units will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.
• It offers insights into the director's holdings and potential alignment with shareholder interests.

Key Dates